Sort
50,496 grants matching “lung cancer”
Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons
$570,918Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2013 · CA
Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung SABR
$570,911Amit Sawant · University Of Maryland Baltimore · R01 · FY2019 · CA
Targeting FAK-NEDD9 protein-protein interaction to prevent focal adhesion assembly and vascular proliferation in pulmonary arterial hypertension
$570,887Bradley Maron · University Of Maryland Baltimore · R01 · FY2024 · HL
Stroger Hospital of Cook County, Department of Surgery,*
$570,787Howard A Zaren · Hektoen Institute For Medical Research · U10 · FY2007 · CA
Faith Moves Mountains: A CBPR Appalachian Wellness & Cancer Prevention Program
$570,775Nancy E Schoenberg · University Of Kentucky · R24 · FY2010 · MD
Tools for Linking and Mining image and Genomic Data in Non-Small Cell Lung Cancer
$570,769Sandy A Napel · Stanford University · R01 · FY2014 · CA
Nonmyeloablative allogeneic PBSC in globin disorders
$570,763John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts
$570,759Charles M Rudin · Sloan-Kettering Inst Can Research · U01 · FY2016 · CA
Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts
$570,759Charles M Rudin · Sloan-Kettering Inst Can Research · U01 · FY2015 · CA
Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts
$570,759Charles M Rudin · Sloan-Kettering Inst Can Research · U01 · FY2017 · CA
Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts
$570,759Charles M Rudin · Sloan-Kettering Inst Can Research · U01 · FY2018 · CA
Core-009
$570,611Stephen B Gruber · University Of Southern California · P30 · FY2017 · CA
Transcriptional heterogeneity and regulatory mechanisms in tumor microenvironment
$570,593Sridhar Hannenhalli · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
The role of Galectin-1 in shaping the immune suppressive landscape in head and neck cancer
$570,587Quynh-Thu X Le · Stanford University · R01 · FY2022 · DE
Single Cell Genome-Wide Myeloid Response Profiling in Immunotherapy
$570,518Allon Moshe Klein · Harvard Medical School · R01 · FY2018 · CA
Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies
$570,484Vito Quaranta · Vanderbilt University · R01 · FY2018 · CA
Tissue Management Shared Resource
$570,465Adam Yopp · Ut Southwestern Medical Center · P30 · FY2020 · CA
Optical Probes & Methods for Imaging Integrin Expression
$570,346Samuel Achilefu · Washington University · R01 · FY2007 · CA
Raman Molecular Imaging for Early Detection of Colon Cancer
$570,346Olav Solgaard · Stanford University · R01 · FY2016 · CA
Study interactions between lung microbiota and immune cells in NSCLC
$570,287Chen Zhao · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
CANCER CENTER SUPPORT GRANT
$570,265Institute For Cancer Prevention · P30 · FY2005 · CA
Automated Planning and Robotic Delivery of Needle Biopsies under CT Image Guidance
$570,176Michael Yip · University Of California, San Diego · R01 · FY2024 · CA
PD-1/PD-L1 modulation in cancer therapy
$570,133Drew M. Pardoll · Johns Hopkins University · R01 · FY2024 · CA
Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease
$570,092Adam O Goldstein · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Molecular and Genetic Analysis of Lung Cancer Survival
$570,057Harvard University (Sch Of Public Hlth) · R01 · FY2003 · CA